These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

487 related items for PubMed ID: 29297057

  • 1. Association of Cardiovascular Risk With Inhaled Long-Acting Bronchodilators in Patients With Chronic Obstructive Pulmonary Disease: A Nested Case-Control Study.
    Wang MT, Liou JT, Lin CW, Tsai CL, Wang YH, Hsu YJ, Lai JH.
    JAMA Intern Med; 2018 Feb 01; 178(2):229-238. PubMed ID: 29297057
    [Abstract] [Full Text] [Related]

  • 2. Risk of Severe Cardiovascular Events From Add-On Tiotropium in Chronic Obstructive Pulmonary Disease.
    Liou JT, Lin CW, Tsai CL, Wang YH, Lai JH, Hsu YJ, Wang MT.
    Mayo Clin Proc; 2018 Oct 01; 93(10):1462-1473. PubMed ID: 30104044
    [Abstract] [Full Text] [Related]

  • 3. Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study.
    Suissa S, Dell'Aniello S, Ernst P.
    Lancet Respir Med; 2018 Nov 01; 6(11):855-862. PubMed ID: 30343028
    [Abstract] [Full Text] [Related]

  • 4. Comparative Cardiovascular and Cerebrovascular Safety of Inhaled Long-Acting Bronchodilators in Patients with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study.
    Dong YH, Chang CH, Gagne JJ, Hsu CL, Lai MS.
    Pharmacotherapy; 2016 Jan 01; 36(1):26-37. PubMed ID: 26799347
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Risk of Cardiovascular and Cerebrovascular Events in COPD Patients Treated With Long-Acting β2-Agonist Combined With a Long-Acting Muscarinic or Inhaled Corticosteroid.
    Samp JC, Joo MJ, Schumock GT, Calip GS, Pickard AS, Lee TA.
    Ann Pharmacother; 2017 Nov 01; 51(11):945-953. PubMed ID: 28677404
    [Abstract] [Full Text] [Related]

  • 9. Relationship of inhaled long-acting bronchodilators with cardiovascular outcomes among patients with stable COPD: a meta-analysis and systematic review of 43 randomized trials.
    Li C, Cheng W, Guo J, Guan W.
    Int J Chron Obstruct Pulmon Dis; 2019 Nov 01; 14():799-808. PubMed ID: 31114181
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study.
    Kozma CM, Paris AL, Plauschinat CA, Slaton T, Mackowiak JI.
    BMC Pulm Med; 2011 Dec 22; 11():61. PubMed ID: 22192866
    [Abstract] [Full Text] [Related]

  • 12. Correlation of Inhaled Long-Acting Bronchodilators With Adverse Cardiovascular Outcomes in Patients With Stable COPD: A Bayesian Network Meta-Analysis of Randomized Controlled Trials.
    Wu J, Ye Y, Li C, Zhou W, Chang R.
    J Cardiovasc Pharmacol; 2019 Sep 22; 74(3):255-265. PubMed ID: 31306366
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparisons of exacerbations and mortality among LAMA/LABA combinations in stable chronic obstructive pulmonary disease: systematic review and Bayesian network meta-analysis.
    Lee HW, Park J, Jang EJ, Lee CH.
    Respir Res; 2020 Nov 25; 21(1):310. PubMed ID: 33238986
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparative cardiovascular safety of LABA/LAMA FDC versus LABA/ICS FDC in patients with chronic obstructive pulmonary disease: a population-based cohort study with a target trial emulation framework.
    Chen CY, Pan SW, Hsu CC, Liu JJ, Kumamaru H, Dong YH.
    Respir Res; 2023 Sep 29; 24(1):239. PubMed ID: 37775734
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.